Names and Addresses of Representatives. The Union shall inform the City in writing as to the names and addresses of its officers, negotiating committee members, shop stewards and any other persons who are authorized representatives of the Union in matters which are appropriate under the provisions of this Agreement. The Union shall also inform the City in writing of any changes to such list of names.
Names and Addresses of Representatives. The Union shall inform the Foundation in writing as to the names and addresses of its officers, negotiating committee members, shop stewards and any other persons who are authorized representatives of the Union in matters which are appropriate under the provisions of this Agreement. The Union shall also inform the Foundation in writing of any changes to such list of names.
Names and Addresses of Representatives. The Union will inform the Company in writing as to the names and addresses of its officers, negotiating committee members, shop stewards and any other persons who are authorized representatives of the Union in matters which are appropriate under the provisions of this agreement. The Union will also inform the Company in writing of any changes to such list of names.
Names and Addresses of Representatives. As to the 2024 Notes, the 2029 Notes, the 2039 Notes, the 2049 Notes and the 2059 Notes (and designated to act on behalf of the other Underwriters or other Representatives): BofA Securities, Inc. 00 Xxxxxxxxxxx Xxxxx, XX0-000-00-00 Xxx Xxxx, Xxx Xxxx 00000 Facsimile: (000) 000-0000 Attention: High Grade Debt Capital Markets Transaction Management/Legal Barclays Capital Inc. 000 Xxxxxxx Xxxxxx Xxx Xxxx, Xxx Xxxx 00000 Attention: Syndicate Registration Facsimile: (000) 000-0000 Citigroup Global Markets Inc. 000 Xxxxxxxxx Xxxxxx Xxx Xxxx, Xxx Xxxx 00000 Attention: General Counsel Facsimile: (000) 000-0000 U.S. Bancorp Investments, Inc. 000 Xxxxx Xxxxx Xxxxxx, 26th Floor Charlotte, North Carolina 28202 Attention: Debt Capital Markets Facsimile: (000) 000-0000 Xxxxx Fargo Securities, LLC 000 Xxxxx Xxxxx Xxxxxx, 5th Floor Charlotte, North Carolina 28202 Attention: Transaction Management SCHEDULE III List of each Issuer Free Writing Prospectus to be included in the Time of Sale Information: • Final term sheet, dated July 23, 2019, relating to the 2024 Notes, the 2029 Notes, the 2039 Notes, the 2049 Notes and the 2059 Notes, as filed pursuant to Rule 433 under the Securities Act. SCHEDULE IV Issuer Free Writing Prospectus Filed Pursuant to Rule 433 Registration Statement No. 333-216150 July 23, 2019 UNITEDHEALTH GROUP INCORPORATED FINAL TERM SHEET Dated July 23, 2019 $750,000,000 2.375% NOTES DUE AUGUST 15, 2024 $1,000,000,000 2.875% NOTES DUE AUGUST 15, 2029 $1,250,000,000 3.500% NOTES DUE AUGUST 15, 2039 $1,250,000,000 3.700% NOTES DUE AUGUST 15, 2049 $1,250,000,000 3.875% NOTES DUE AUGUST 15, 2059 Issuer: UnitedHealth Group Incorporated Ratings (Xxxxx’x / S&P / Fitch)*: [Intentionally omitted] Note Type: SEC Registered (No. 333-216150) Trade Date: July 23, 2019 Settlement Date (T+2): July 25, 2019 Maturity Date: August 15, 2024 (the “2024 Notes”) August 15, 2029 (the “2029 Notes”) August 15, 2039 (the “2039 Notes”) August 15, 2049 (the “2049 Notes”) August 15, 2059 (the “2059 Notes”) Principal Amount Offered: $750,000,000 (2024 Notes) $1,000,000,000 (2029 Notes) $1,250,000,000 (2039 Notes) $1,250,000,000 (2049 Notes) $1,250,000,000 (2059 Notes) Price to Public (Issue Price): 99.975% (2024 Notes) 99.973% (2029 Notes) 99.016% (2039 Notes) 99.656% (2049 Notes) 99.112% (2059 Notes) Net Proceeds (Before Expenses) to Issuer: $747,187,500 (99.625%) (2024 Notes) $995,230,000 (99.523%) (2029 Notes) $1,229,575,000 (98.366%) (2039 Notes) $1,236,325,000 (98.906%) (2049 Not...
Names and Addresses of Representatives. Citigroup Global Markets Inc. 300 Xxxxxxxxx Xxxxxx Xxx Xxxx, XX 00000 Attention: General Counsel (Fax: 200-000-0000) J.X. Xxxxxx Securities Inc. 200 Xxxx Xxxxxx Xxx Xxxx, XX 00000 Attention: Investment Grade Syndicate Desk (Fax: 200-000-0000) Information Provided by the Underwriter: The Underwriters have furnished to the Company for use in the Prospectus Supplement:
Names and Addresses of Representatives. As to the 20 Notes (and designated to act on behalf of the other Underwriters or other Representatives): SCHEDULE III List of each Issuer Free Writing Prospectus to be included in the Time of Sale Information: • Final term sheet, dated , 20 , relating to the 20 Notes, as filed pursuant to Rule 433 under the Securities Act. SCHEDULE IV Form of Final Term Sheet for 20 Notes Issuer: UnitedHealth Group Incorporated Ratings: Note Type: SEC Registered (No. 333-[ ]) Trade Date: [ ], 20[ ] Settlement Date (T+ 3): [ ], 20[ ] Maturity Date: [ ], 20[ ] Principal Amount Offered: $[ ] Price to Public (Issue Price): [ ]% Interest Rate: [ ]% Interest Payment Dates: [ ] and [ ], commencing [ ], 20[ ] Benchmark: [ ]% due [ / / ] Benchmark Yield: [ ]% Spread to Benchmark: [ ] basis points Re-offer Yield: [ ]% Optional Redemption Provisions: Prior to [ , 20 ], make-whole call at any time at a discount rate of U.S. Treasury plus [ ] basis points; par call on and after [ , 20 ]. [Change of Control: [ ]] CUSIP: ISIN: Joint Book-Runners: [ ] Co-Managers: [ ] Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time. The issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting XXXXX on the SEC Web site at xxx.xxx.xxx. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling [ ] at [( ) - ], [ ] at [( ) - ] or [ ] at [( ) - ]. Any disclaimer or other notice that may appear below is not applicable to this communication and should be disregarded. Such disclaimer or notice was automatically generated as a result of this communication being sent by Bloomberg or another email system.
Names and Addresses of Representatives. Designated Representatives: Xxxxxxx, Xxxxx & Co. Address for Notices, etc.: 00 Xxxxx Xxxxxx Xxx Xxxx, Xxx Xxxx 00000 Pursuant to Section 7(e) of the Underwriting Agreement, the accountants shall furnish letters to the Underwriters to the effect that:
Names and Addresses of Representatives. As to the 20___ Notes (and designated to act on behalf of the other Underwriters or other Representatives): ________________________ XXXXXXXX XXX List of each Issuer Free Writing Prospectus to be included in the Time of Sale Information: • Final term sheet, dated ___________, 20___, relating to the 20___ Notes, as filed pursuant to Rule 433 under the Securities Act. XXXXXXXX XX Form of Final Term Sheet for 20___Notes Issuer: UnitedHealth Group Incorporated Ratings (Xxxxx’x / S&P)*: Note Type: SEC Registered (No. 333-[________]) Trade Date: [___________], 20[___] Settlement Date (T+ 3): [___________], 20[___] Maturity Date: [___________], 20[___] Principal Amount Offered: $[__________] Price to Public (Issue Price): [______]% Interest Rate: [______]% Interest Payment Dates: [______] and [______], commencing [______], 20[___] Benchmark: [______]% due [___/___/___] Benchmark Yield: [______]% Spread to Benchmark: [______] basis points Re-offer Yield: [______]% Optional Redemption Provisions: Prior to [___________], 20[___], make-whole call at any time at a discount rate of U.S. Treasury plus [___] basis points; par call on and after [__________ ___, 20__]. [Change of Control: [______]] CUSIP/ISIN: Joint Book-Runners: [______] Managers: [______] Co-Managers: [______] * Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision, suspension or withdrawal at any time. The issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting XXXXX on the SEC Web site at xxx.xxx.xxx. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling [______] at [(___) ___-____], [______] at [(___) ___-____] or [______]at [(___) ___-____]. Any disclaimer or other notice that may appear below is not applicable to this communication and should be disregarded. Such disclaimer or notice was automatically generated as a result of this communication being sent by Bloomberg or another email system.
Names and Addresses of Representatives. Wachovia Capital Markets, LLC Attention: Xxx Xxxxxxxxxx 000 X. Xxxxxxx Xxxxxx Xxxxxxxxx, XX 00000 Citigroup Global Markets Inc. Attention: Xxxxx Xxxxxx 000 Xxxxxxxxx Xxxxxx, 0xx Xxxxx Xxx Xxxx, XX 00000
Names and Addresses of Representatives. The respective principal amounts of the Debt Securities to be purchased by each of the Underwriters are set forth opposite their names in Schedule A hereto. The provisions of the Underwriting Agreement are incorporated herein by reference. The Closing will take place at___ A.M., New York City time, on ___________ , 199__, at the offices of ___________________________________ . The Securities will be made available for checking and packaging at the office of not later than 2:00 p.m., New York City time, on the business day prior to the Delivery Date. Please signify your acceptance by signing the enclosed response to us in the space provided and returning it to us. Very truly yours, SCHEDULE A DEBT SECURITIES UNDERWRITER PRINCIPAL AMOUNT __________ Total __________
